Financing led by institutional investors, with participation from new investor Eli Lilly and Company Inclusive of this investment, a total of $123 million in equity financing received from ...
The MarketWatch News Department was not involved in the creation of this content. -- Financing led by institutional investors, with participation from new investor Eli Lilly and Company -- Inclusive ...
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results